nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanidine—KCNQ4—ear—skin cancer	0.0324	0.0567	CbGeAlD
Guanidine—Azotaemia—Vismodegib—skin cancer	0.0282	0.0791	CcSEcCtD
Guanidine—KCNC1—nerve—skin cancer	0.0204	0.0357	CbGeAlD
Guanidine—KCNQ1—ear—skin cancer	0.0186	0.0326	CbGeAlD
Guanidine—Folliculitis—Vemurafenib—skin cancer	0.0148	0.0414	CcSEcCtD
Guanidine—KCNS3—hair follicle—skin cancer	0.0133	0.0233	CbGeAlD
Guanidine—Folliculitis—Imiquimod—skin cancer	0.0126	0.0353	CcSEcCtD
Guanidine—KCNA1—nerve—skin cancer	0.0121	0.0213	CbGeAlD
Guanidine—KCNF1—nipple—skin cancer	0.0103	0.0181	CbGeAlD
Guanidine—KCNS2—female reproductive system—skin cancer	0.00955	0.0167	CbGeAlD
Guanidine—KCNB1—epithelium—skin cancer	0.00943	0.0165	CbGeAlD
Guanidine—KCNG4—head—skin cancer	0.00938	0.0164	CbGeAlD
Guanidine—KCNB2—head—skin cancer	0.00938	0.0164	CbGeAlD
Guanidine—KCNH4—head—skin cancer	0.00938	0.0164	CbGeAlD
Guanidine—KCNC3—epithelium—skin cancer	0.00916	0.016	CbGeAlD
Guanidine—KCNS3—nipple—skin cancer	0.00903	0.0158	CbGeAlD
Guanidine—RNASE1—nipple—skin cancer	0.00876	0.0154	CbGeAlD
Guanidine—KCNH5—head—skin cancer	0.00858	0.015	CbGeAlD
Guanidine—Eruption—Dactinomycin—skin cancer	0.00852	0.0239	CcSEcCtD
Guanidine—KCNS1—epithelium—skin cancer	0.00847	0.0149	CbGeAlD
Guanidine—KCNG3—lymphoid tissue—skin cancer	0.00842	0.0148	CbGeAlD
Guanidine—Folliculitis—Dactinomycin—skin cancer	0.00834	0.0234	CcSEcCtD
Guanidine—KCNS2—head—skin cancer	0.00798	0.014	CbGeAlD
Guanidine—KCNA6—head—skin cancer	0.00798	0.014	CbGeAlD
Guanidine—KCNV1—head—skin cancer	0.0075	0.0131	CbGeAlD
Guanidine—KCNV2—head—skin cancer	0.00711	0.0125	CbGeAlD
Guanidine—Atrial fibrillation—Vemurafenib—skin cancer	0.00711	0.0199	CcSEcCtD
Guanidine—KCNA3—lymphoid tissue—skin cancer	0.00686	0.012	CbGeAlD
Guanidine—ALDH2—hair follicle—skin cancer	0.00683	0.012	CbGeAlD
Guanidine—KCNG3—head—skin cancer	0.00678	0.0119	CbGeAlD
Guanidine—KCNH1—head—skin cancer	0.00678	0.0119	CbGeAlD
Guanidine—KCNC2—head—skin cancer	0.00678	0.0119	CbGeAlD
Guanidine—KCNC1—mammalian vulva—skin cancer	0.00675	0.0118	CbGeAlD
Guanidine—KCNQ1—neck—skin cancer	0.00657	0.0115	CbGeAlD
Guanidine—KCNA5—connective tissue—skin cancer	0.00654	0.0115	CbGeAlD
Guanidine—DLG4—female reproductive system—skin cancer	0.00629	0.011	CbGeAlD
Guanidine—KCNS3—epithelium—skin cancer	0.00608	0.0107	CbGeAlD
Guanidine—Atrial fibrillation—Imiquimod—skin cancer	0.00606	0.017	CcSEcCtD
Guanidine—KCNG1—head—skin cancer	0.00604	0.0106	CbGeAlD
Guanidine—KCNH3—head—skin cancer	0.00604	0.0106	CbGeAlD
Guanidine—KCND1—female reproductive system—skin cancer	0.00602	0.0106	CbGeAlD
Guanidine—Purpura—Imiquimod—skin cancer	0.00596	0.0167	CcSEcCtD
Guanidine—KCNB1—head—skin cancer	0.00585	0.0103	CbGeAlD
Guanidine—KCNH8—head—skin cancer	0.00585	0.0103	CbGeAlD
Guanidine—KCNS3—skin of body—skin cancer	0.00578	0.0101	CbGeAlD
Guanidine—Petechiae—Temozolomide—skin cancer	0.00576	0.0162	CcSEcCtD
Guanidine—KCNC3—head—skin cancer	0.00568	0.00996	CbGeAlD
Guanidine—KCNQ5—female reproductive system—skin cancer	0.00563	0.00986	CbGeAlD
Guanidine—KCNA3—head—skin cancer	0.00553	0.00969	CbGeAlD
Guanidine—KCNA4—head—skin cancer	0.00553	0.00969	CbGeAlD
Guanidine—Irritability—Imiquimod—skin cancer	0.00548	0.0154	CcSEcCtD
Guanidine—KCNS3—mammalian vulva—skin cancer	0.00527	0.00924	CbGeAlD
Guanidine—KCNS1—head—skin cancer	0.00526	0.00922	CbGeAlD
Guanidine—KCNA2—head—skin cancer	0.00526	0.00922	CbGeAlD
Guanidine—DLG4—head—skin cancer	0.00526	0.00922	CbGeAlD
Guanidine—Eruption—Docetaxel—skin cancer	0.00513	0.0144	CcSEcCtD
Guanidine—RNASE1—mammalian vulva—skin cancer	0.00512	0.00897	CbGeAlD
Guanidine—KCNC4—head—skin cancer	0.00503	0.00882	CbGeAlD
Guanidine—KCND1—head—skin cancer	0.00503	0.00882	CbGeAlD
Guanidine—GAMT—mammalian vulva—skin cancer	0.00498	0.00873	CbGeAlD
Guanidine—KCNQ3—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00484	0.0662	CbGpPWpGaD
Guanidine—KCNQ2—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00484	0.0662	CbGpPWpGaD
Guanidine—KCNQ4—head—skin cancer	0.00483	0.00847	CbGeAlD
Guanidine—KCNH7—head—skin cancer	0.00483	0.00847	CbGeAlD
Guanidine—KCNC1—head—skin cancer	0.00483	0.00847	CbGeAlD
Guanidine—KCNQ5—head—skin cancer	0.0047	0.00824	CbGeAlD
Guanidine—Decreased appetite—Vismodegib—skin cancer	0.00466	0.0131	CcSEcCtD
Guanidine—ALDH2—nipple—skin cancer	0.00463	0.00812	CbGeAlD
Guanidine—KCNA5—female reproductive system—skin cancer	0.00461	0.00808	CbGeAlD
Guanidine—KCNQ3—female reproductive system—skin cancer	0.00452	0.00791	CbGeAlD
Guanidine—Throat sore—Docetaxel—skin cancer	0.00437	0.0123	CcSEcCtD
Guanidine—Oropharyngeal discomfort—Docetaxel—skin cancer	0.00434	0.0122	CcSEcCtD
Guanidine—KCNF1—head—skin cancer	0.00431	0.00755	CbGeAlD
Guanidine—Abdominal pain—Vismodegib—skin cancer	0.00424	0.0119	CcSEcCtD
Guanidine—KCNQ2—female reproductive system—skin cancer	0.00416	0.00728	CbGeAlD
Guanidine—KCNH6—female reproductive system—skin cancer	0.00412	0.00722	CbGeAlD
Guanidine—KCNQ1—mammalian vulva—skin cancer	0.00388	0.0068	CbGeAlD
Guanidine—KCNA3—lymph node—skin cancer	0.00387	0.00678	CbGeAlD
Guanidine—KCNA5—head—skin cancer	0.00385	0.00675	CbGeAlD
Guanidine—Vascular purpura—Temozolomide—skin cancer	0.00385	0.0108	CcSEcCtD
Guanidine—KCNS3—head—skin cancer	0.00377	0.00661	CbGeAlD
Guanidine—KCNQ3—head—skin cancer	0.00377	0.00661	CbGeAlD
Guanidine—Flushing—Imiquimod—skin cancer	0.00369	0.0104	CcSEcCtD
Guanidine—KCNA2—lymph node—skin cancer	0.00368	0.00645	CbGeAlD
Guanidine—DLG4—lymph node—skin cancer	0.00368	0.00645	CbGeAlD
Guanidine—Diarrhoea—Vismodegib—skin cancer	0.00367	0.0103	CcSEcCtD
Guanidine—SLC22A4—neck—skin cancer	0.00358	0.00627	CbGeAlD
Guanidine—Purpura—Temozolomide—skin cancer	0.00357	0.01	CcSEcCtD
Guanidine—GAMT—head—skin cancer	0.00356	0.00624	CbGeAlD
Guanidine—KCNC4—lymph node—skin cancer	0.00352	0.00617	CbGeAlD
Guanidine—Liver function test abnormal—Dactinomycin—skin cancer	0.00351	0.00986	CcSEcCtD
Guanidine—KCNQ2—head—skin cancer	0.00347	0.00608	CbGeAlD
Guanidine—Oropharyngeal pain—Docetaxel—skin cancer	0.00347	0.00973	CcSEcCtD
Guanidine—KCNH6—head—skin cancer	0.00344	0.00603	CbGeAlD
Guanidine—Affect lability—Temozolomide—skin cancer	0.00339	0.00951	CcSEcCtD
Guanidine—Rash—Vismodegib—skin cancer	0.00338	0.00948	CcSEcCtD
Guanidine—Dermatitis—Vismodegib—skin cancer	0.00338	0.00947	CcSEcCtD
Guanidine—KCNQ1—female reproductive system—skin cancer	0.00332	0.00582	CbGeAlD
Guanidine—KCNQ5—lymph node—skin cancer	0.00329	0.00577	CbGeAlD
Guanidine—SLC22A3—nipple—skin cancer	0.00329	0.00577	CbGeAlD
Guanidine—KCND2—head—skin cancer	0.00329	0.00576	CbGeAlD
Guanidine—ALDH2—connective tissue—skin cancer	0.00328	0.00576	CbGeAlD
Guanidine—Mood swings—Temozolomide—skin cancer	0.00326	0.00915	CcSEcCtD
Guanidine—Ataxia—Temozolomide—skin cancer	0.00324	0.00908	CcSEcCtD
Guanidine—Nausea—Vismodegib—skin cancer	0.00318	0.00893	CcSEcCtD
Guanidine—Hypotension—Vemurafenib—skin cancer	0.00309	0.00868	CcSEcCtD
Guanidine—Palpitations—Imiquimod—skin cancer	0.00306	0.00858	CcSEcCtD
Guanidine—Irritability—Fluorouracil—skin cancer	0.00303	0.0085	CcSEcCtD
Guanidine—Ataxia—Fluorouracil—skin cancer	0.00298	0.00837	CcSEcCtD
Guanidine—ALDH2—skin of body—skin cancer	0.00297	0.0052	CbGeAlD
Guanidine—KCNA1—head—skin cancer	0.00288	0.00505	CbGeAlD
Guanidine—Dry mouth—Imiquimod—skin cancer	0.00288	0.00808	CcSEcCtD
Guanidine—Decreased appetite—Vemurafenib—skin cancer	0.00288	0.00808	CcSEcCtD
Guanidine—KCND3—head—skin cancer	0.00287	0.00502	CbGeAlD
Guanidine—Lightheadedness—Docetaxel—skin cancer	0.00282	0.00792	CcSEcCtD
Guanidine—KCNQ1—head—skin cancer	0.00278	0.00486	CbGeAlD
Guanidine—Tachycardia—Imiquimod—skin cancer	0.00276	0.00773	CcSEcCtD
Guanidine—Hyperhidrosis—Imiquimod—skin cancer	0.00273	0.00766	CcSEcCtD
Guanidine—ALDH2—mammalian vulva—skin cancer	0.0027	0.00474	CbGeAlD
Guanidine—KCNA5—lymph node—skin cancer	0.0027	0.00473	CbGeAlD
Guanidine—Anorexia—Imiquimod—skin cancer	0.00269	0.00755	CcSEcCtD
Guanidine—DLG4—L1CAM interactions—SCN10A—skin cancer	0.00267	0.0365	CbGpPWpGaD
Guanidine—KCNS3—lymph node—skin cancer	0.00264	0.00463	CbGeAlD
Guanidine—Flushing—Bleomycin—skin cancer	0.00262	0.00735	CcSEcCtD
Guanidine—Body temperature increased—Vemurafenib—skin cancer	0.00262	0.00734	CcSEcCtD
Guanidine—RNASE1—lymph node—skin cancer	0.00256	0.00449	CbGeAlD
Guanidine—Paraesthesia—Imiquimod—skin cancer	0.00253	0.00711	CcSEcCtD
Guanidine—KCNH2—nipple—skin cancer	0.00253	0.00444	CbGeAlD
Guanidine—GAMT—lymph node—skin cancer	0.00249	0.00437	CbGeAlD
Guanidine—Decreased appetite—Imiquimod—skin cancer	0.00245	0.00689	CcSEcCtD
Guanidine—Flushing—Dactinomycin—skin cancer	0.00244	0.00686	CcSEcCtD
Guanidine—Atrial fibrillation—Docetaxel—skin cancer	0.00242	0.00678	CcSEcCtD
Guanidine—ALDH2—lymphoid tissue—skin cancer	0.0024	0.00421	CbGeAlD
Guanidine—SLC22A5—nipple—skin cancer	0.00239	0.00419	CbGeAlD
Guanidine—Hallucination—Temozolomide—skin cancer	0.00237	0.00665	CcSEcCtD
Guanidine—SLC22A3—connective tissue—skin cancer	0.00233	0.00409	CbGeAlD
Guanidine—Feeling abnormal—Imiquimod—skin cancer	0.00233	0.00653	CcSEcCtD
Guanidine—ALDH2—female reproductive system—skin cancer	0.00232	0.00406	CbGeAlD
Guanidine—Anaemia—Bleomycin—skin cancer	0.00227	0.00637	CcSEcCtD
Guanidine—Diarrhoea—Vemurafenib—skin cancer	0.00226	0.00636	CcSEcCtD
Guanidine—SLC22A3—Synaptic Vesicle Pathway—SYP—skin cancer	0.00226	0.0309	CbGpPWpGaD
Guanidine—Abdominal pain—Imiquimod—skin cancer	0.00223	0.00626	CcSEcCtD
Guanidine—Body temperature increased—Imiquimod—skin cancer	0.00223	0.00626	CcSEcCtD
Guanidine—Flushing—Temozolomide—skin cancer	0.00221	0.0062	CcSEcCtD
Guanidine—Leukopenia—Bleomycin—skin cancer	0.0022	0.00617	CcSEcCtD
Guanidine—Dizziness—Vemurafenib—skin cancer	0.00219	0.00614	CcSEcCtD
Guanidine—Ataxia—Docetaxel—skin cancer	0.00215	0.00604	CcSEcCtD
Guanidine—Anaemia—Dactinomycin—skin cancer	0.00212	0.00595	CcSEcCtD
Guanidine—Liver function test abnormal—Docetaxel—skin cancer	0.00211	0.00593	CcSEcCtD
Guanidine—Rash—Vemurafenib—skin cancer	0.00209	0.00586	CcSEcCtD
Guanidine—Dermatitis—Vemurafenib—skin cancer	0.00209	0.00585	CcSEcCtD
Guanidine—Leukopenia—Dactinomycin—skin cancer	0.00205	0.00576	CcSEcCtD
Guanidine—Confusional state—Bleomycin—skin cancer	0.00202	0.00568	CcSEcCtD
Guanidine—KCND3—lymph node—skin cancer	0.00201	0.00352	CbGeAlD
Guanidine—Nausea—Vemurafenib—skin cancer	0.00197	0.00552	CcSEcCtD
Guanidine—Thrombocytopenia—Bleomycin—skin cancer	0.00196	0.00551	CcSEcCtD
Guanidine—KCNQ1—lymph node—skin cancer	0.00194	0.00341	CbGeAlD
Guanidine—Tremor—Temozolomide—skin cancer	0.00194	0.00545	CcSEcCtD
Guanidine—ALDH2—head—skin cancer	0.00193	0.00339	CbGeAlD
Guanidine—Diarrhoea—Imiquimod—skin cancer	0.00193	0.00542	CcSEcCtD
Guanidine—SLC22A3—mammalian vulva—skin cancer	0.00192	0.00337	CbGeAlD
Guanidine—Anaemia—Temozolomide—skin cancer	0.00192	0.00538	CcSEcCtD
Guanidine—Anorexia—Bleomycin—skin cancer	0.00191	0.00537	CcSEcCtD
Guanidine—Hypotension—Bleomycin—skin cancer	0.00187	0.00526	CcSEcCtD
Guanidine—Dizziness—Imiquimod—skin cancer	0.00187	0.00524	CcSEcCtD
Guanidine—KCNQ2—L1CAM interactions—SCN10A—skin cancer	0.00186	0.0254	CbGpPWpGaD
Guanidine—KCNQ3—L1CAM interactions—SCN10A—skin cancer	0.00186	0.0254	CbGpPWpGaD
Guanidine—Leukopenia—Temozolomide—skin cancer	0.00186	0.00521	CcSEcCtD
Guanidine—Palpitations—Temozolomide—skin cancer	0.00183	0.00514	CcSEcCtD
Guanidine—Thrombocytopenia—Dactinomycin—skin cancer	0.00183	0.00514	CcSEcCtD
Guanidine—SLC22A4—female reproductive system—skin cancer	0.00181	0.00317	CbGeAlD
Guanidine—Paraesthesia—Bleomycin—skin cancer	0.0018	0.00505	CcSEcCtD
Guanidine—Anorexia—Dactinomycin—skin cancer	0.00178	0.005	CcSEcCtD
Guanidine—Rash—Imiquimod—skin cancer	0.00178	0.005	CcSEcCtD
Guanidine—Dermatitis—Imiquimod—skin cancer	0.00178	0.00499	CcSEcCtD
Guanidine—Anaemia—Fluorouracil—skin cancer	0.00177	0.00495	CcSEcCtD
Guanidine—Decreased appetite—Bleomycin—skin cancer	0.00174	0.00489	CcSEcCtD
Guanidine—DLG4—CREB phosphorylation through the activation of Ras—BRAF—skin cancer	0.00173	0.0237	CbGpPWpGaD
Guanidine—Dry mouth—Temozolomide—skin cancer	0.00173	0.00484	CcSEcCtD
Guanidine—Leukopenia—Fluorouracil—skin cancer	0.00171	0.0048	CcSEcCtD
Guanidine—Confusional state—Temozolomide—skin cancer	0.00171	0.00479	CcSEcCtD
Guanidine—Nausea—Imiquimod—skin cancer	0.00168	0.00471	CcSEcCtD
Guanidine—Thrombocytopenia—Temozolomide—skin cancer	0.00166	0.00465	CcSEcCtD
Guanidine—Feeling abnormal—Bleomycin—skin cancer	0.00165	0.00464	CcSEcCtD
Guanidine—SLC22A3—female reproductive system—skin cancer	0.00165	0.00289	CbGeAlD
Guanidine—Hyperhidrosis—Temozolomide—skin cancer	0.00164	0.00459	CcSEcCtD
Guanidine—Decreased appetite—Dactinomycin—skin cancer	0.00163	0.00456	CcSEcCtD
Guanidine—Anorexia—Temozolomide—skin cancer	0.00161	0.00453	CcSEcCtD
Guanidine—Body temperature increased—Bleomycin—skin cancer	0.00159	0.00445	CcSEcCtD
Guanidine—Confusional state—Fluorouracil—skin cancer	0.00157	0.00441	CcSEcCtD
Guanidine—Feeling abnormal—Dactinomycin—skin cancer	0.00154	0.00433	CcSEcCtD
Guanidine—SLC22A5—skin of body—skin cancer	0.00153	0.00269	CbGeAlD
Guanidine—Thrombocytopenia—Fluorouracil—skin cancer	0.00153	0.00428	CcSEcCtD
Guanidine—Tachycardia—Fluorouracil—skin cancer	0.00152	0.00427	CcSEcCtD
Guanidine—Paraesthesia—Temozolomide—skin cancer	0.00152	0.00426	CcSEcCtD
Guanidine—Anorexia—Fluorouracil—skin cancer	0.00149	0.00417	CcSEcCtD
Guanidine—Abdominal pain—Dactinomycin—skin cancer	0.00148	0.00415	CcSEcCtD
Guanidine—Body temperature increased—Dactinomycin—skin cancer	0.00148	0.00415	CcSEcCtD
Guanidine—Decreased appetite—Temozolomide—skin cancer	0.00147	0.00413	CcSEcCtD
Guanidine—Flushing—Docetaxel—skin cancer	0.00147	0.00412	CcSEcCtD
Guanidine—Hypotension—Fluorouracil—skin cancer	0.00146	0.00409	CcSEcCtD
Guanidine—SLC22A1—head—skin cancer	0.00144	0.00252	CbGeAlD
Guanidine—DLG4—Post NMDA receptor activation events—BRAF—skin cancer	0.00143	0.0195	CbGpPWpGaD
Guanidine—Paraesthesia—Fluorouracil—skin cancer	0.0014	0.00393	CcSEcCtD
Guanidine—Feeling abnormal—Temozolomide—skin cancer	0.00139	0.00391	CcSEcCtD
Guanidine—KCND2—Circadian rythm related genes—NKX2-1—skin cancer	0.00138	0.0189	CbGpPWpGaD
Guanidine—SLC22A3—head—skin cancer	0.00138	0.00241	CbGeAlD
Guanidine—Decreased appetite—Fluorouracil—skin cancer	0.00135	0.0038	CcSEcCtD
Guanidine—ALDH2—lymph node—skin cancer	0.00135	0.00237	CbGeAlD
Guanidine—Abdominal pain—Temozolomide—skin cancer	0.00134	0.00375	CcSEcCtD
Guanidine—Body temperature increased—Temozolomide—skin cancer	0.00134	0.00375	CcSEcCtD
Guanidine—SLC22A8—head—skin cancer	0.00132	0.00232	CbGeAlD
Guanidine—DLG4—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—skin cancer	0.00131	0.0179	CbGpPWpGaD
Guanidine—Feeling abnormal—Fluorouracil—skin cancer	0.00128	0.00361	CcSEcCtD
Guanidine—Diarrhoea—Dactinomycin—skin cancer	0.00128	0.00359	CcSEcCtD
Guanidine—Anaemia—Docetaxel—skin cancer	0.00127	0.00358	CcSEcCtD
Guanidine—KCNH2—female reproductive system—skin cancer	0.00127	0.00222	CbGeAlD
Guanidine—Rash—Bleomycin—skin cancer	0.00126	0.00355	CcSEcCtD
Guanidine—Dermatitis—Bleomycin—skin cancer	0.00126	0.00355	CcSEcCtD
Guanidine—Leukopenia—Docetaxel—skin cancer	0.00123	0.00346	CcSEcCtD
Guanidine—Body temperature increased—Fluorouracil—skin cancer	0.00123	0.00346	CcSEcCtD
Guanidine—Palpitations—Docetaxel—skin cancer	0.00122	0.00342	CcSEcCtD
Guanidine—KCNH7—Circadian rythm related genes—NKX2-1—skin cancer	0.00121	0.0165	CbGpPWpGaD
Guanidine—SLC22A5—female reproductive system—skin cancer	0.0012	0.0021	CbGeAlD
Guanidine—Nausea—Bleomycin—skin cancer	0.00119	0.00334	CcSEcCtD
Guanidine—Rash—Dactinomycin—skin cancer	0.00118	0.00331	CcSEcCtD
Guanidine—Diarrhoea—Temozolomide—skin cancer	0.00116	0.00325	CcSEcCtD
Guanidine—Dry mouth—Docetaxel—skin cancer	0.00115	0.00322	CcSEcCtD
Guanidine—Confusional state—Docetaxel—skin cancer	0.00113	0.00318	CcSEcCtD
Guanidine—Dizziness—Temozolomide—skin cancer	0.00112	0.00314	CcSEcCtD
Guanidine—DLG4—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—skin cancer	0.00112	0.0153	CbGpPWpGaD
Guanidine—Nausea—Dactinomycin—skin cancer	0.00111	0.00312	CcSEcCtD
Guanidine—Thrombocytopenia—Docetaxel—skin cancer	0.0011	0.00309	CcSEcCtD
Guanidine—Tachycardia—Docetaxel—skin cancer	0.0011	0.00308	CcSEcCtD
Guanidine—Anorexia—Docetaxel—skin cancer	0.00107	0.00301	CcSEcCtD
Guanidine—Rash—Temozolomide—skin cancer	0.00107	0.00299	CcSEcCtD
Guanidine—Diarrhoea—Fluorouracil—skin cancer	0.00107	0.00299	CcSEcCtD
Guanidine—Dermatitis—Temozolomide—skin cancer	0.00107	0.00299	CcSEcCtD
Guanidine—SLC22A4—lymph node—skin cancer	0.00106	0.00185	CbGeAlD
Guanidine—KCNH2—head—skin cancer	0.00106	0.00185	CbGeAlD
Guanidine—Hypotension—Docetaxel—skin cancer	0.00105	0.00295	CcSEcCtD
Guanidine—Dizziness—Fluorouracil—skin cancer	0.00103	0.00289	CcSEcCtD
Guanidine—Paraesthesia—Docetaxel—skin cancer	0.00101	0.00284	CcSEcCtD
Guanidine—DLG4—Axon guidance—SCN10A—skin cancer	0.00101	0.0138	CbGpPWpGaD
Guanidine—Nausea—Temozolomide—skin cancer	0.001	0.00282	CcSEcCtD
Guanidine—Rash—Fluorouracil—skin cancer	0.000983	0.00276	CcSEcCtD
Guanidine—Dermatitis—Fluorouracil—skin cancer	0.000982	0.00276	CcSEcCtD
Guanidine—Decreased appetite—Docetaxel—skin cancer	0.000978	0.00274	CcSEcCtD
Guanidine—SLC22A3—lymph node—skin cancer	0.000963	0.00169	CbGeAlD
Guanidine—Feeling abnormal—Docetaxel—skin cancer	0.000927	0.0026	CcSEcCtD
Guanidine—Nausea—Fluorouracil—skin cancer	0.000926	0.0026	CcSEcCtD
Guanidine—Body temperature increased—Docetaxel—skin cancer	0.000889	0.0025	CcSEcCtD
Guanidine—Abdominal pain—Docetaxel—skin cancer	0.000889	0.0025	CcSEcCtD
Guanidine—DLG4—CREB phosphorylation through the activation of Ras—HRAS—skin cancer	0.000796	0.0109	CbGpPWpGaD
Guanidine—Diarrhoea—Docetaxel—skin cancer	0.00077	0.00216	CcSEcCtD
Guanidine—Dizziness—Docetaxel—skin cancer	0.000744	0.00209	CcSEcCtD
Guanidine—KCNH2—lymph node—skin cancer	0.000741	0.0013	CbGeAlD
Guanidine—DLG4—Developmental Biology—SCN10A—skin cancer	0.000719	0.00983	CbGpPWpGaD
Guanidine—Rash—Docetaxel—skin cancer	0.000709	0.00199	CcSEcCtD
Guanidine—Dermatitis—Docetaxel—skin cancer	0.000709	0.00199	CcSEcCtD
Guanidine—KCNQ3—Axon guidance—SCN10A—skin cancer	0.000702	0.00959	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—SCN10A—skin cancer	0.000702	0.00959	CbGpPWpGaD
Guanidine—SLC22A5—lymph node—skin cancer	0.0007	0.00123	CbGeAlD
Guanidine—Nausea—Docetaxel—skin cancer	0.000668	0.00188	CcSEcCtD
Guanidine—DLG4—Post NMDA receptor activation events—HRAS—skin cancer	0.000655	0.00896	CbGpPWpGaD
Guanidine—DLG4—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—skin cancer	0.000604	0.00825	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—RASA1—skin cancer	0.000579	0.00791	CbGpPWpGaD
Guanidine—SLC22A4—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.00055	0.00752	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—SCN10A—skin cancer	0.000501	0.00685	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—SCN10A—skin cancer	0.000501	0.00685	CbGpPWpGaD
Guanidine—DLG4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—skin cancer	0.000491	0.00672	CbGpPWpGaD
Guanidine—KCNH8—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNG3—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNA6—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNC1—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNG1—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNS1—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCND1—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNC4—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNA5—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNF1—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNS2—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNV1—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNH4—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNC3—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNH5—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNA2—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNA4—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNA7—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNB2—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNV2—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNA10—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNH1—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNH3—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—KCNG4—Neuronal System—BRAF—skin cancer	0.000429	0.00587	CbGpPWpGaD
Guanidine—SLC22A3—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000415	0.00567	CbGpPWpGaD
Guanidine—SLC22A5—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000413	0.00565	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—RASA1—skin cancer	0.000413	0.00565	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—RASA1—skin cancer	0.000403	0.00551	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—RASA1—skin cancer	0.000403	0.00551	CbGpPWpGaD
Guanidine—KCND2—Circadian rythm related genes—CDK4—skin cancer	0.00039	0.00533	CbGpPWpGaD
Guanidine—KCNA3—Neuronal System—BRAF—skin cancer	0.000383	0.00523	CbGpPWpGaD
Guanidine—SLC22A8—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000374	0.00511	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PLIN2—skin cancer	0.000373	0.0051	CbGpPWpGaD
Guanidine—DLG4—Transmission across Chemical Synapses—BRAF—skin cancer	0.000369	0.00505	CbGpPWpGaD
Guanidine—KCNQ5—Neuronal System—BRAF—skin cancer	0.000365	0.00499	CbGpPWpGaD
Guanidine—KCNQ4—Neuronal System—BRAF—skin cancer	0.000365	0.00499	CbGpPWpGaD
Guanidine—KCNH7—Circadian rythm related genes—CDK4—skin cancer	0.000341	0.00466	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PLIN2—skin cancer	0.000326	0.00446	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PLIN2—skin cancer	0.000326	0.00446	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PLIN2—skin cancer	0.000326	0.00446	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PLIN2—skin cancer	0.000309	0.00423	CbGpPWpGaD
Guanidine—KCNG2—Neuronal System—BRAF—skin cancer	0.000306	0.00418	CbGpPWpGaD
Guanidine—KCNS3—Neuronal System—BRAF—skin cancer	0.000306	0.00418	CbGpPWpGaD
Guanidine—KCNC2—Neuronal System—BRAF—skin cancer	0.000306	0.00418	CbGpPWpGaD
Guanidine—GAMT—Metabolism—CSPG4—skin cancer	0.000301	0.00411	CbGpPWpGaD
Guanidine—KCNA3—BDNF signaling pathway—HRAS—skin cancer	0.000299	0.00408	CbGpPWpGaD
Guanidine—KCND3—Neuronal System—BRAF—skin cancer	0.000298	0.00407	CbGpPWpGaD
Guanidine—KCNB1—Neuronal System—BRAF—skin cancer	0.00029	0.00396	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—RASA1—skin cancer	0.000288	0.00393	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—RASA1—skin cancer	0.000288	0.00393	CbGpPWpGaD
Guanidine—DLG4—Neuronal System—BRAF—skin cancer	0.000283	0.00387	CbGpPWpGaD
Guanidine—SLC22A4—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000279	0.00382	CbGpPWpGaD
Guanidine—KCNQ1—Neuronal System—BRAF—skin cancer	0.000265	0.00363	CbGpPWpGaD
Guanidine—KCND2—Neuronal System—BRAF—skin cancer	0.000265	0.00363	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—CSPG4—skin cancer	0.000263	0.00359	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—CSPG4—skin cancer	0.000263	0.00359	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—CSPG4—skin cancer	0.000263	0.00359	CbGpPWpGaD
Guanidine—KCNH6—Neuronal System—BRAF—skin cancer	0.00026	0.00356	CbGpPWpGaD
Guanidine—SLC22A2—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.00026	0.00356	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—CSPG4—skin cancer	0.000249	0.00341	CbGpPWpGaD
Guanidine—SLC22A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.000242	0.00331	CbGpPWpGaD
Guanidine—KCNA1—Neuronal System—BRAF—skin cancer	0.000235	0.00322	CbGpPWpGaD
Guanidine—KCNH7—Neuronal System—BRAF—skin cancer	0.000232	0.00317	CbGpPWpGaD
Guanidine—DLG4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—skin cancer	0.000226	0.00309	CbGpPWpGaD
Guanidine—ALDH2—Transmission across Chemical Synapses—BRAF—skin cancer	0.000223	0.00305	CbGpPWpGaD
Guanidine—SLC22A3—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000211	0.00288	CbGpPWpGaD
Guanidine—SLC22A5—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.00021	0.00287	CbGpPWpGaD
Guanidine—GAMT—Metabolism—ENO2—skin cancer	0.000204	0.00279	CbGpPWpGaD
Guanidine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—skin cancer	0.000204	0.00279	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—CDK4—skin cancer	0.000203	0.00277	CbGpPWpGaD
Guanidine—KCNA10—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNS2—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNG3—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNC1—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNA6—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNG1—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNS1—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNH8—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCND1—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNA5—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNC4—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNH4—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNF1—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNV1—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNH5—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNC3—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNA2—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNH3—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNV2—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNA7—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNH1—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNG4—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNB2—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNA4—Neuronal System—HRAS—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNQ2—Neuronal System—BRAF—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—KCNQ3—Neuronal System—BRAF—skin cancer	0.000197	0.0027	CbGpPWpGaD
Guanidine—SLC22A8—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.00019	0.0026	CbGpPWpGaD
Guanidine—KCNQ1—SIDS Susceptibility Pathways—IL6—skin cancer	0.000186	0.00254	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PLIN2—skin cancer	0.000182	0.00249	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—ENO2—skin cancer	0.000179	0.00244	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—ENO2—skin cancer	0.000179	0.00244	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—ENO2—skin cancer	0.000179	0.00244	CbGpPWpGaD
Guanidine—KCNA3—Neuronal System—HRAS—skin cancer	0.000176	0.00241	CbGpPWpGaD
Guanidine—ALDH2—Neuronal System—BRAF—skin cancer	0.000171	0.00234	CbGpPWpGaD
Guanidine—DLG4—Transmission across Chemical Synapses—HRAS—skin cancer	0.00017	0.00232	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—ENO2—skin cancer	0.000169	0.00232	CbGpPWpGaD
Guanidine—KCNQ5—Neuronal System—HRAS—skin cancer	0.000168	0.00229	CbGpPWpGaD
Guanidine—KCNQ4—Neuronal System—HRAS—skin cancer	0.000168	0.00229	CbGpPWpGaD
Guanidine—KCND2—Circadian rythm related genes—TP53—skin cancer	0.000166	0.00227	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—NRAS—skin cancer	0.000158	0.00216	CbGpPWpGaD
Guanidine—KCND2—Circadian rythm related genes—IL6—skin cancer	0.000152	0.00207	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—CSPG4—skin cancer	0.000147	0.00201	CbGpPWpGaD
Guanidine—KCNH7—Circadian rythm related genes—TP53—skin cancer	0.000145	0.00198	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—CDK4—skin cancer	0.000141	0.00193	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—CDK4—skin cancer	0.000141	0.00193	CbGpPWpGaD
Guanidine—KCNC2—Neuronal System—HRAS—skin cancer	0.000141	0.00192	CbGpPWpGaD
Guanidine—KCNG2—Neuronal System—HRAS—skin cancer	0.000141	0.00192	CbGpPWpGaD
Guanidine—KCNS3—Neuronal System—HRAS—skin cancer	0.000141	0.00192	CbGpPWpGaD
Guanidine—KCND3—Neuronal System—HRAS—skin cancer	0.000137	0.00187	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—KRAS—skin cancer	0.000136	0.00186	CbGpPWpGaD
Guanidine—KCNB1—Neuronal System—HRAS—skin cancer	0.000133	0.00182	CbGpPWpGaD
Guanidine—KCNH7—Circadian rythm related genes—IL6—skin cancer	0.000133	0.00181	CbGpPWpGaD
Guanidine—SLC22A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000132	0.00181	CbGpPWpGaD
Guanidine—DLG4—Neuronal System—HRAS—skin cancer	0.00013	0.00178	CbGpPWpGaD
Guanidine—SLC22A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000123	0.00168	CbGpPWpGaD
Guanidine—KCND2—Neuronal System—HRAS—skin cancer	0.000122	0.00167	CbGpPWpGaD
Guanidine—KCNQ1—Neuronal System—HRAS—skin cancer	0.000122	0.00167	CbGpPWpGaD
Guanidine—KCNH6—Neuronal System—HRAS—skin cancer	0.00012	0.00164	CbGpPWpGaD
Guanidine—GAMT—Metabolism—ERCC2—skin cancer	0.000119	0.00162	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—HRAS—skin cancer	0.000115	0.00158	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—NRAS—skin cancer	0.000113	0.00154	CbGpPWpGaD
Guanidine—DLG4—Axon guidance—IL6—skin cancer	0.000111	0.00151	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—NRAS—skin cancer	0.00011	0.0015	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—NRAS—skin cancer	0.00011	0.0015	CbGpPWpGaD
Guanidine—KCNA1—Neuronal System—HRAS—skin cancer	0.000108	0.00148	CbGpPWpGaD
Guanidine—KCNH7—Neuronal System—HRAS—skin cancer	0.000107	0.00146	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PLIN2—skin cancer	0.000104	0.00142	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—ERCC2—skin cancer	0.000104	0.00142	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—ERCC2—skin cancer	0.000104	0.00142	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—ERCC2—skin cancer	0.000104	0.00142	CbGpPWpGaD
Guanidine—ALDH2—Transmission across Chemical Synapses—HRAS—skin cancer	0.000103	0.0014	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—ENO2—skin cancer	9.98e-05	0.00136	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—ERCC2—skin cancer	9.84e-05	0.00135	CbGpPWpGaD
Guanidine—KCNH2—Neuronal System—BRAF—skin cancer	9.82e-05	0.00134	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—KRAS—skin cancer	9.69e-05	0.00133	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—KRAS—skin cancer	9.46e-05	0.00129	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—KRAS—skin cancer	9.46e-05	0.00129	CbGpPWpGaD
Guanidine—KCNQ2—Neuronal System—HRAS—skin cancer	9.06e-05	0.00124	CbGpPWpGaD
Guanidine—KCNQ3—Neuronal System—HRAS—skin cancer	9.06e-05	0.00124	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—CSPG4—skin cancer	8.39e-05	0.00115	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—HRAS—skin cancer	8.24e-05	0.00113	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—HRAS—skin cancer	8.04e-05	0.0011	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—HRAS—skin cancer	8.04e-05	0.0011	CbGpPWpGaD
Guanidine—SLC22A2—Transmission across Chemical Synapses—BRAF—skin cancer	8e-05	0.00109	CbGpPWpGaD
Guanidine—DLG4—Developmental Biology—IL6—skin cancer	7.89e-05	0.00108	CbGpPWpGaD
Guanidine—ALDH2—Neuronal System—HRAS—skin cancer	7.86e-05	0.00107	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—NRAS—skin cancer	7.84e-05	0.00107	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—NRAS—skin cancer	7.84e-05	0.00107	CbGpPWpGaD
Guanidine—KCNQ2—Axon guidance—IL6—skin cancer	7.7e-05	0.00105	CbGpPWpGaD
Guanidine—KCNQ3—Axon guidance—IL6—skin cancer	7.7e-05	0.00105	CbGpPWpGaD
Guanidine—SLC22A1—Transmission across Chemical Synapses—BRAF—skin cancer	7.45e-05	0.00102	CbGpPWpGaD
Guanidine—GAMT—Metabolism—PTGS2—skin cancer	7.12e-05	0.000973	CbGpPWpGaD
Guanidine—KCNH2—SIDS Susceptibility Pathways—IL6—skin cancer	6.88e-05	0.00094	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—KRAS—skin cancer	6.75e-05	0.000923	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—KRAS—skin cancer	6.75e-05	0.000923	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PLIN2—skin cancer	6.53e-05	0.000893	CbGpPWpGaD
Guanidine—KCNS3—Metabolism—PTGS2—skin cancer	6.22e-05	0.000851	CbGpPWpGaD
Guanidine—KCNC2—Metabolism—PTGS2—skin cancer	6.22e-05	0.000851	CbGpPWpGaD
Guanidine—KCNG2—Metabolism—PTGS2—skin cancer	6.22e-05	0.000851	CbGpPWpGaD
Guanidine—SLC22A2—Neuronal System—BRAF—skin cancer	6.13e-05	0.000838	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PLIN2—skin cancer	6.09e-05	0.000832	CbGpPWpGaD
Guanidine—KCNB1—Metabolism—PTGS2—skin cancer	5.9e-05	0.000806	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—ERCC2—skin cancer	5.8e-05	0.000793	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—HRAS—skin cancer	5.74e-05	0.000785	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—HRAS—skin cancer	5.74e-05	0.000785	CbGpPWpGaD
Guanidine—SLC22A1—Neuronal System—BRAF—skin cancer	5.71e-05	0.000781	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ENO2—skin cancer	5.7e-05	0.00078	CbGpPWpGaD
Guanidine—KCNQ2—Developmental Biology—IL6—skin cancer	5.49e-05	0.000751	CbGpPWpGaD
Guanidine—KCNQ3—Developmental Biology—IL6—skin cancer	5.49e-05	0.000751	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—CSPG4—skin cancer	5.26e-05	0.00072	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—CSPG4—skin cancer	4.91e-05	0.000671	CbGpPWpGaD
Guanidine—KCNH2—Neuronal System—HRAS—skin cancer	4.51e-05	0.000617	CbGpPWpGaD
Guanidine—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	3.68e-05	0.000503	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ENO2—skin cancer	3.58e-05	0.000489	CbGpPWpGaD
Guanidine—ALDH2—Metabolism—PTGS2—skin cancer	3.48e-05	0.000475	CbGpPWpGaD
Guanidine—SLC22A1—Transmission across Chemical Synapses—HRAS—skin cancer	3.43e-05	0.000468	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ENO2—skin cancer	3.34e-05	0.000456	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—ERCC2—skin cancer	3.31e-05	0.000453	CbGpPWpGaD
Guanidine—SLC22A2—Neuronal System—HRAS—skin cancer	2.82e-05	0.000385	CbGpPWpGaD
Guanidine—SLC22A1—Neuronal System—HRAS—skin cancer	2.63e-05	0.000359	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—ERCC2—skin cancer	2.08e-05	0.000284	CbGpPWpGaD
Guanidine—SLC22A3—Metabolism—PTGS2—skin cancer	1.99e-05	0.000272	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—ERCC2—skin cancer	1.94e-05	0.000265	CbGpPWpGaD
Guanidine—SLC22A2—Metabolism—PTGS2—skin cancer	1.25e-05	0.00017	CbGpPWpGaD
Guanidine—SLC22A1—Metabolism—PTGS2—skin cancer	1.16e-05	0.000159	CbGpPWpGaD
